short communication
The Transition to Dolutegravir-Based Regimens in the Presence of High- Level Drug Resistance to Nucleotide Reverse Transcriptase Inhibitors: Does It Deserve More Attention?
Vinie Kouamou*, Chiratidzo E Ndhlovu and Justen Manasa
Current Research on HIV/AIDS
Volume 5